Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Huntington Disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Humans < Huntington Disease < Hyalin  Facettes :

List of bibliographic references indexed by Huntington Disease

Number of relevant bibliographic references: 271.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000078 (2015) Calum D. Moulton [Royaume-Uni] ; C W P. Hopkins [Royaume-Uni] ; W Richard Bevan-Jones [Royaume-Uni]Reply: Suicidality in Huntington's Disease: Distinguishing lithium from other psychotropic medications.
000189 (2015) Michele Raja [Italie] ; Francesco Soleti [Italie] ; Anna Rita Bentivoglio [Italie]Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior.
000292 (2015) Raymond Y. Lo [Taïwan] ; Karla P. Figueroa ; Stefan M. Pulst ; Chi-Ying Lin ; Susan Perlman ; George Wilmot ; Christopher Gomez ; Jeremy Schmahmann ; Henry Paulson ; Vikram G. Shakkottai ; Sarah Ying ; Theresa Zesiewicz ; Khalaf Bushara ; Michael Geschwind ; Guangbin Xia ; S H Subramony ; Tetsuo Ashizawa ; Sheng-Han KuoCoenzyme Q10 and spinocerebellar ataxias.
000299 (2015) Eman M. Khedr [Égypte] ; Mohamed A. Ahmed ; Anwar M. Ali ; Reda Badry ; John C. RothwellChanges in motor cortical excitability in patients with Sydenham's chorea.
000345 (2015) Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe VernyA phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
000366 (2014) Ashwini K. Rao ; Karen S. Marder ; Jasim Uddin ; Brian C. RakitinVariability in interval production is due to timing dependent deficits in Huntington’s disease
000393 (2014) Marina Papoutsi [Royaume-Uni] ; Izelle Labuschagne ; Sarah J. Tabrizi ; Julie C. StoutThe cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.
000399 (2014) Anne-Wil Heemskerk [Pays-Bas] ; Berit M. Verbist ; Johan Marinus ; Bas Heijnen ; Elisabeth V. Sjögren ; Raymund A C. RoosThe Huntington's Disease Dysphagia Scale.
000406 (2014) Edward J. Wild ; Sarah J. TabriziTargets for future clinical trials in Huntington's disease: What's in the pipeline?
000409 (2014) Calum D. Moulton ; C W P. Hopkins ; W Richard Bevan-JonesSystematic review of pharmacological treatments for depressive symptoms in Huntington's disease.
000417 (2014) Anne Rosser [Royaume-Uni] ; Clive N. SvendsenStem cells for cell replacement therapy: a therapeutic strategy for HD?
000459 (2014) Abhishek Chandra ; Ashu Johri ; M. Flint BealProspects for Neuroprotective Therapies in Prodromal Huntington's disease
000463 (2014) Rainer Hoffmann [Allemagne] ; Sven H. Stüwe ; Oliver Goetze ; Matthias Banasch ; Peter Klotz ; Carsten Lukas ; Martin Tegenthoff ; Christian Beste ; Michael Orth ; Carsten SaftProgressive hepatic mitochondrial dysfunction in premanifest Huntington's disease.
000472 (2014) Thomas Philips [États-Unis] ; Jeffrey D. Rothstein ; Mahmoud A. PouladiPreclinical models: needed in translation? A Pro/Con debate.
000474 (2014) Eirini Kalliolia [Royaume-Uni] ; Edina Silajdži ; Rajasree Nambron ; Nathan R. Hill ; Anisha Doshi ; Chris Frost ; Hilary Watt ; Peter Hindmarsh ; Maria Björkqvist ; Thomas T. WarnerPlasma melatonin is reduced in Huntington's disease.
000490 (2014) Jane S. Paulsen [États-Unis] ; Jeffrey D. Long [États-Unis]Onset of Huntington disease: Can it be purely cognitive?
000503 (2014) Jeannie M. Padowski [États-Unis] ; Kurt E. Weaver [États-Unis] ; Todd L. Richards [États-Unis] ; Mercy Y. Laurino [États-Unis] ; Ali Samii [États-Unis] ; Elizabeth H. Aylward [États-Unis] ; Kevin E. Conley [États-Unis]Neurochemical correlates of caudate atrophy in Huntington disease
000507 (2014) Emily R. Fisher [Canada] ; Michael R. HaydenMultisource ascertainment of Huntington disease in Canada: prevalence and population at risk.
000515 (2014) Ellen P. Hart [Pays-Bas] ; Eve M. Dumas ; Anne Schoonderbeek ; Shalane C. Wolthuis ; Erik W. Van Zwet ; Raymund A C. RoosMotor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
000520 (2014) David S. Howland [États-Unis] ; Ignacio Munoz-SanjuanMind the gap: models in multiple species needed for therapeutic development in Huntington's disease.
000521 (2014) Wenzhen Duan [États-Unis] ; Mali Jiang [États-Unis] ; Jing Jin [États-Unis]Metabolism in HD - Still a relevant mechanism?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Huntington Disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Huntington Disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Huntington Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024